Indivior Pharmaceuticals, Inc.: Opioid-Related Disorders trials

The registry lists 32 Opioid-Related Disorders studies with Indivior Pharmaceuticals, Inc. as lead sponsor. 0 are open to participants now and 20 have results posted.

Phase 1 7Phase 2 7Phase 3 3Phase 4 7No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male ParticipantsCompletedNCT05974046Phase 1Results posted
• Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection LocationsCompletedNCT05704543Phase 4Results posted
• Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use DisorderCompletedNCT04976855Phase 1Results posted
• INDV-2000 First in HumanCompletedNCT04413552Phase 1Results posted
• SUBLOCADE Rapid Initiation Extension StudyCompletedNCT04060654Phase 4Results posted
• SUBLOCADE Rapid Initiation StudyCompletedNCT03993392Phase 4Results posted
• Evaluation of Long-term Buprenorphine Plasma ExposureCompletedNCT03752528Results posted
• Open-Label Treatment Extension StudyCompletedNCT02896296Phase 3Results posted
• Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use DisorderCompletedNCT02510014Phase 3Results posted
• Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of BuprenorphineCompletedNCT02357901Phase 3Results posted
• Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid DisorderCompletedNCT02044094Phase 2Results posted
• Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent PopulationCompletedNCT02038790Phase 4Results posted
• Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent SubjectsCompletedNCT01738503Phase 2Results posted
• Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)CompletedNCT00725608Results posted
• Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)CompletedNCT00723749Results posted
• Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)CompletedNCT00723697Results posted
• Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)CompletedNCT00684073Phase 4Results posted
• Safety and Tolerability of Buprenorphine/Naloxone Film StripsCompletedNCT00640835Phase 2Results posted
• Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/NaloxoneCompletedNCT00637000Phase 2Results posted
• A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)CompletedNCT00605033Phase 4Results posted
• Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use DisorderCompletedNCT06384157Phase 2
• Evaluating the SUBLOCADE Treatment Exit StrategyCompletedNCT05878210
• SUBLOCADE Long-term OutcomesCompletedNCT05860959
• An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long TermTerminatedNCT04577144
• Study of a Novel Subcutaneous Depot Formulation of BuprenorphineCompletedNCT03715634Phase 1
• An Observational Study of Environmental and SocioEconomic Factors in Opioid RecoveryCompletedNCT03604861
• Single Ascending Dose Study of RBP-6000CompletedNCT03002961Phase 1
• Single-dose, Study of RBP-6000 in Opioid Dependent IndividualsCompletedNCT02765867Phase 1
• Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use DisorderCompletedNCT02559973Phase 1
• A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine AbuseCompletedNCT01846481Phase 2
• Transfer of Subjects From Subutex/Suboxone to RBP-6300CompletedNCT01582347Phase 2
• Multicentre Trial of Suboxone in Opiate-dependent Subjects in TaiwanCompletedNCT00901875Phase 4